The global hemodynamic monitoring devices market is anticipated to grow at a moderate CAGR of 3.2% during the forecast period (2024-2031). The hemodynamic monitoring devices play a critical role in monitoring of patient’s vitals. Therefore, the ongoing technological advancements have further increased their demand owing to higher efficiency. For instance, in October 2023, Mindray’s BeneVision N-Series integrated Edwards Lifesciences’ FloTrac sensor for hemodynamic monitoring in the patient monitoring system. The FloTrac sensor technology expands the N-Series capability to monitor patients' hemodynamic condition. It gives healthcare providers a vital tool to proactively address any possible decline in a patient's condition and to personalize fluid management strategies in both surgical and acute care environments.
Browse the full report description of “Hemodynamic Monitoring Devices Market Size, Share & Trends Analysis Report by System (Minimally Invasive Monitoring Devices, Invasive Monitoring Devices, and Non-Invasive Monitoring Devices), by End-User (Hospitals, Homecare, and Laboratory) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/hemodynamic-monitoring-devices-market
Further, in May 2021, Royal Philips announced the integration of its Interventional Hemodynamic System and portable Patient Monitor IntelliVue X3, providing advanced hemodynamic (blood flow) measurements at the tableside in the cath lab and continuous monitoring of key vital signs throughout the patient journey.
Technically advanced product launches are further aiding market growth. For instance, in September 2023, iRhythm Technologies, Inc. announced the US launch of its next-generation Zio monitor and enhanced Zio long-term continuous monitoring (LTCM) service. Zio monitor is iRhythm’s smallest, lightest, and thinnest cardiac monitor, enhancing the cardiac monitoring experience for patients and healthcare providers together with new service enhancements. The new Zio monitor is a prescription-only ECG monitor, which is an integral part of the Zio LTCM service.
Market Coverage
• The market number available for – 2023-2031
• Base year- 2023
• Forecast period- 2024-2031
• Segment Covered-
o By System
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Koninklijke Philips NV, Edwards Lifesciences Corp., Masimo, Getinge AB, and GE Healthcare others.
Key questions addressed by the report
Global Hemodynamic Monitoring Devices Market Report Segment
By System
By End-User
Global Hemodynamic Monitoring Devices Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/hemodynamic-monitoring-devices-market